Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Boehringer Ingelheim
Harvard Business School
McKesson
Medtronic

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Apotex Inc. v. Daiichi Sankyo, Inc. (Fed. Cir. 2014)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Small Molecule Drugs cited in Apotex Inc. v. Daiichi Sankyo, Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Apotex Inc. v. Daiichi Sankyo, Inc. (Fed. Cir. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-16 53 listed two patents in the Orange Book: U.S. Patent No. 5,616,599 (“the ’599 patent”), which is scheduled… NDA holder must identify each patent for “which a claim of patent infringement could reasonably…referenced patent expires; and [2] a “Paragraph IV” certification, which asserts that a listed patent is …finding that the patent is invalid or not infringed. (CC) The patent information submitted…of a patent-based or regulatory exclusivity period (such as a thirty-month stay due to patent litigation External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Medtronic
McKesson
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.